Clinical confirmation to demonstrate similarity for a biosimilar pegfilgrastim: a 3-way randomized equivalence study for a proposed biosimilar pegfilgrastim versus US-licensed and EU-approved reference products in breast cancer patients receiving mye
about
Clinical confirmation to demonstrate similarity for a biosimilar pegfilgrastim: a 3-way randomized equivalence study for a proposed biosimilar pegfilgrastim versus US-licensed and EU-approved reference products in breast cancer patients receiving mye
description
scientific article published on 06 September 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Clinical confirmation to demon ...... cancer patients receiving mye
@en
Clinical confirmation to demon ...... cancer patients receiving mye
@nl
type
label
Clinical confirmation to demon ...... cancer patients receiving mye
@en
Clinical confirmation to demon ...... cancer patients receiving mye
@nl
prefLabel
Clinical confirmation to demon ...... cancer patients receiving mye
@en
Clinical confirmation to demon ...... cancer patients receiving mye
@nl
P2093
P2860
P1476
Clinical confirmation to demon ...... myelosuppressive chemotherapy
@en
P2093
Kalpna Desai
Priya Misra
Sanyukta Kher
P2860
P2888
P356
10.1186/S40164-018-0114-9
P407
P50
P577
2018-09-06T00:00:00Z
P6179
1106805931